Mesenchymal Stem Cells Market Segmentation:
Source Segment Analysis
The umbilical cord segment is estimated to gain the largest market share in the year 2035, attributed to the growing awareness amongst people about the high regenerative properties of umbilical cord cells, along with the increasing trend of storing the cells for the future. It is highly beneficial for treating genetic disorders, immune deficiencies, and several types of cancers. For instance, it was projected that around 450,000 people are currently living with immune deficiency diseases (PIDDs) in USA.
Furthermore, the bone marrow segment is estimated to obtain the second-largest share of the market over the forecast period. Bone marrow mesenchymal stem cells (MSCs) have different properties than other somatic stem cells and that’s the reason they are considered to be unique types of adult stem cells. MSCs are self-renewing multipotent cells and are most suitable for bone tissue regeneration. Cell generation is used in several treatments such as Alzheimer's treatment and to cure spinal cord injuries, cancer, type 1 diabetes, osteoarthritis, Parkinson’s disease, cancer, heart disease, and others. The higher prevalence of these diseases is set to hike the demand for bone marrow mesenchymal stem cells (MSCs). As of 2019, nearly 8 million people across the globe are estimated to be living with Parkinson’s disease.
Our in-depth analysis of the global market includes the following segments:
|
By Type |
|
|
By Source |
|
|
By Application |
|
